Colchicine did not significantly reduce the incidence of two common cardiovascular complications: Perioperative AF and myocardial injury after non-cardiac surgery (MINS). However, there was an encouraging signal of benefit for colchicine to reduce the incidence of adverse cardiovascular outcomes in patients undergoing major noncardiac thoracic surgery, which requires further study.
In this interview, David Conen MD, MPH, and Joseph E. Marine MD, MBA, FACC discuss ESC Hot Line: COP-AF - Colchicine for the prevention of perioperative atrial fibrillation after major thoracic surgery.
Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research